Technology
March 9, 2008 - Biomaterials company SyntheMed Inc. has received FDA approval of its pre-market approval (PMA) application for REPEL-CV Adhesion Barrier for use in pediatric cardiac surgery patients.
March 09, 2009
News
March 9, 2009 - A study, presented at the 21st European Congress of Radiology, comparing the performance of TeraRecon’s Aquarius iNtuition solution with a competitor’s solution for assessment of Cardiac CT studies, concluded that TeraRecon’s solution increased performance with less operator interaction.
March 09, 2009
News
March 6, 2009 – VectraCor Inc. submitted its 510(k) application to the FDA in December for a new technology to derive 22-lead ECG function from only five electrodes
March 06, 2009Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News
March 6, 2009 - Transoma Medical Inc.’s Sleuth AT wireless, automated implantable cardiac monitoring system was implanted in its first U.S. patient on March 2 at the Ohio State University Medical Center.
March 06, 2009News
Researchers at the Section of Cardiology, Department of Medicine, University of Chicago Hospitals said their findings, published in the March 1 issue of the American Journal of Cardiology, Vol. 103, Issue 5, suggest SPECT perfusion imaging should be conducted on patients who have abnormal heart rate recovery (HRR) on routine exercise treadmill testing.
March 06, 2009
News
March 6, 2009 - Atritech Inc. will release PROTECT AF trial results on WATCHMAN LAA closure technology comparing the device to the current standard of care, warfarin therapy, in patients with non-valvular atrial fibrillation.
March 06, 2009Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
March 6, 2009 – New research published in the March edition of the HeartRhythm Journal reveals that black and Hispanic patients who were eligible for cardiac resynchronization therapy with defibrillator (CRT-D) were less likely to receive therapy than eligible white patients.
March 06, 2009
News
March 6, 2009 - American College of Cardiology’s (ACC) President W. Douglas Weaver, M.D., participated in yesterday’s White House Summit on Health Care and released the following comments:
March 06, 2009
Technology
March 6, 2009 – At the ECR congress, Barco unveiled an upgraded version of the Nio Color 3MP diagnostic display system, featuring a high-bright LCD panel.
March 05, 2009Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology
March 5, 2009 - In the first six-year follow-up of a pivotal study of any drug-eluting stent, the clinical benefits of the CYPHER Sirolimus-eluting Coronary Stent compared to a bare-metal stent (BMS) were sustained according to data presented at the Cardiovascular Revascularization Therapies conference.
March 05, 2009
News
March 5, 2009 - Bristol-Myers Squibb Company yesterday said it is collaborating with Nissan Chemical Industries Ltd. and Teijin Pharma Ltd.
March 05, 2009News
March 5, 2009 - During the Best Peer Practice "Achieve Measurable Results Through CVIS" Webinar, attendees will learn how to use CVIS data to support quality initiatives and provide instant feedback on performance.
March 05, 2009Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News
March 5, 2009 - CorMatrix Cardiovascular Inc., developer of extracellular matrix (ECM Technology) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, announced the first implant in Europe of the CorMatrix ECM Technology in a patient undergoing cardiac surgery.
March 05, 2009News
March 5, 2009 - TomTec is showcasing its brand-new CardioArena multimodality workstation for Cardio PACS during the upcoming ECR conference in Vienna, Austria. The CardioArena platform is a commercially available solution for 2D, 3D, and 4D imaging data. It serves multimodality platform for all major medical imaging modalities such as ultrasound, MRI and cathlab.
March 05, 2009
News
March 5, 2009 - Prescient Medical Inc. announced it completed enrollment in February of 30 patients in the first phase of its first-in-human clinical trial for the vProtect Luminal Shield, conducted at the Corbic Research Institute in Colombia.
March 05, 2009© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now